Evidence map›Paper›PMID 31576130›Full record

ReviewNeuropsychiatric disease and treatment2019

Transcranial magnetic stimulation for the treatment of anxiety disorder.

Priscila Aparecida Rodrigues, Ana Luiza Zaninotto, Iuri Santana Neville, Cintya Yukie Hayashi, André R Brunoni, Manoel Jacobsen Teixeira, Wellingson Silva Paiva

Open access · goldAbstract readReview
In one paragraph

Review in Neuropsychiatric disease and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Personalization of Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depressive Disorder According to the Existing Psychiatric Comorbidity.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2021
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Priscila Aparecida RodriguesDepartment of Neurology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0001-6105-1061
Ana Luiza ZaninottoDepartment of Neurology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-0639-0612
Iuri Santana NevilleDepartment of Neurology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-8561-9069
Cintya Yukie HayashiDepartment of Neurology, University of São Paulo, São Paulo, Brazil.
André R BrunoniInstitute of Psychiatry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-6310-3571
Manoel Jacobsen TeixeiraDepartment of Neurology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-7974-6045
Wellingson Silva PaivaDepartment of Neurology, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulatory options with the potential to improve mood changes, we highlight repetitive transcranial magnetic stimulation (rTMS). rTMS is a viable therapeutical option for neuropsychiatric dysfunctions of high prevalence and is important for the understanding of pathological and neuropsychological adaptation processes. Even with this potential, and high relevance of intervention, we observe the scarcity of literature that covers this subject. The objective of this study was to carry out a survey of the current literature, using scientific databases for the last five years. We found 32 studies reporting the effects of rTMS on anxiety, 7 on anxiety disorders and 25 on anxiety symptoms as comorbidities of neurological or psychiatric disorders. This survey suggests the need for further studies using TMS for anxiety in order to seek strategies that minimize these anxiety effects on the quality of life of the victims of this disorder.

Indexed as

anxiety disordersreviewtranscranial magnetic stimulationtreatment

Identifiers

PMID31576130
PMCPMC6765211
OpenAlexW2974464060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.